Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06152042 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus

Name: Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus — clinical trial record (NCT06152042)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhasePhase 2

SponsorBiomea Fusion Inc.

Started2023-12-28

View on ClinicalTrials.gov ↗

Phase 2 Trial of BMF-219 in Participants with Type 1 Diabetes Mellitus.

Amendment history 1 change detected by DataLookout

2026-08-29

Reclassified as completed (was terminated)

Trial Details

NCT Number	NCT06152042
Lead Sponsor	Biomea Fusion Inc.
Conditions	Type 1 Diabetes Mellitus
Enrollment	37 participants
Start Date	2023-12-28
Primary Completion	2025-05-20 (estimated)
Study Completion	2025-07-18 (estimated)
Updated on ClinicalTrials.gov	2026-08-28